Positive long-term mortality results from the Balloon Pump-Assisted Coronary Intervention Study (BCIS-1), which evaluated the effect on major complications and mortality of elective use of an intra-aortic balloon pump (IABP) in patients with low ejection fraction undergoing high-risk percutaneous coronary intervention (PCI). Results from 51 months (mean) of follow up showed that elective IABP use during PCI was associated with a 34 percent reduction in all-cause mortality compared to patients who had no planned IABP insertion prior to PCI. The long-term data were presented in an oral session at the American College of Cardiology’s 61st Annual Scientific Session in Chicago.
Download BCIS-1 Results (PDF: 124 KB / 3 Pages)
Download Powerpoint Slides (PPT: 2 MB / 18 Slides)
Physician roundtable discussion of the BCIS-1 Long-Term Mortality Data.
Manesh R. Patel, MD
Duke Clinical Research Institute
Divaka Perera, MD, MRCP
St. Thomas’ Hospital, King’s College London
Eric R. Bates, MD
University of Michigan Health System
Marc Cohen, MD
Newark Beth Israel Medical Center, Mount Sinai School of Medicine